Search Results
Results found for "Structure Therapeutics"
- High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and...
particularly aggressive and heterogeneous disease with few effective targeted therapies and precision therapeutic
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics
- Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...
Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics
- How System-Level GPCR Thinking Prevents Discovery Failures
This feature from Celtarys Research outlines how to structure an HCS workflow that avoids batch effects
- TLR4 biased small molecule modulators
Biased pharmacological modulators provide potential therapeutic benefits, including greater pharmacodynamic
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Display | Manager, CMC Management | Translational R&D openings Must-read publications: New findings on structure-encoded
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
the current status of ligand development targeting LPA receptors to modulate LPA signaling and their therapeutic
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Must-read publications: A structural modeling study revealing non-canonical mechanisms of chemokine-driven
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
study biased signaling pathways, improving our understanding of GPCR functional diversity and their therapeutic
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
extensively studied GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural
- Fluorescence Polarization in GPCR Research
compounds that interact with molecular targets involved in disease pathways is where the development of new therapeutics
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Leverage this model to stay ahead of therapeutic complexity.
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
manner, and triggered the formation of cell condensations that developed aligned, anisotropic neotissue structures
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
Realizing tissue is alive, unpredictable, and full of hidden structure.
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
indicated by the fact that about 40% of all drugs currently used in clinical practice mediate their therapeutic
- 📰 GPCR Weekly News
Detergent Rigidity-Flexibility Balance in Protein Stability. iORbase: a database for the prediction of the structures
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
advancing the understanding of the effects of genetic mutations on GPCR function and provide a proof of therapeutic
- 📰 GPCR Weekly News, October 9 to 15, 2023
Tethered Ligands that Target the µ-Opioid Receptor Design and Synthesis of Novel GPR139 Agonists with Therapeutic
- Curve Shifts Don’t Lie, But Your Eyes Might
right replicate count to balance rigor and efficiency Choose the correct statistical test for your data structure
- Understanding the Journey: Catherine Demery's Path to Addiction Science
It was here that the disciplined structure of industry science helped her re-find purpose and build confidence
- From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations
of shipping early and iterating, many scientific founders keep refining decks, processes, and team structures
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
This is especially useful in GPCRs, where structural similarity happens often and thus cross-reactivity
- Interacting binding insights and conformational consequences of the differential activity of...
way for understanding the CBD pharmacology at a molecular level and aid in harnessing its potential therapeutic
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
competitive edge: Learn to leverage restricted diffusion and rebinding to create drugs with longer therapeutic
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Jefferies Healthcare Conference in London Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic
- From Snapshots to Predictions: Why Mechanism of Action Matters
If you stop at potency, structure–activity relationships (SARs) may look flat.
- VAMP2: a crucial player in the delivery of MOR to the synapse
You can consult the article at the following link: https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function Struct. Mol. Biol. 15:658–664.
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
modulating autophagy and the CDKN1B-CDK2-CCNE1-E2F1 axis and indicate that ARRB1 may be a potential therapeutic
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
continue to propel our quest to unravel the complexities of GPCR signaling and pave the way for novel therapeutic
- Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls
✅ Deep-dive learning paths — Structured progression from foundational concepts to emerging and expert-level














